Indegene Limited

BSE: INDGN544172ISIN INE065X01017

Healthcare
Healthcare Research, Analytics & Technology
BSE 500

BSE listing

Share price

₹597.50+6.30 (+1.07%)

as of 18 Sep 2026

52W high: ₹616.00
52W low: ₹414.90
Off 52W high: -3.00%
1M return: +5.89%
3M return: +12.20%
6M return: +35.63%
1Y return: +1.96%
20D avg volume: 82,057
50 DMA: ₹552.95
200 DMA: ₹513.05

Key ratios Consolidated

Market cap: ₹14,398 Cr
Current price: ₹597.50
52W high / low: ₹616.00 / ₹414.90
Face value: ₹2.00
P/E: 35.91
P/B: —
EPS (TTM): ₹16.64
Book value / share: —
ROE: —
ROCE: 15.40%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-300.80 Cr
Interest cover: 28.20
Dividend yield: 0.38%
Dividend / share (TTM): ₹2.25
Payout: 13.52%
Cash conversion cycle: 83.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	1,063	1,003	942.10	804.20	760.80	755.60	—
	29.00	10.80	19.40	19.70	22.10	25.60	—
	939.40	888.80	826.80	690.80	630.80	631.90	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	659.10	632.40	568.00	515.80	481.50	485.10	—
	6.40	7.20	4.60	3.80	3.70	3.10	—
	44.10	41.80	39.60	23.40	21.60	20.70	—
	229.80	207.40	214.60	147.80	124.00	123.00	—
	152.70	125.40	134.70	133.10	152.10	149.30	—
	0.00	-20.30	0.00	0.00	0.00	0.00	—
	152.70	105.10	134.70	133.10	152.10	149.30	—
	36.50	25.40	31.80	31.00	35.70	31.70	—
	116.20	79.70	102.90	102.10	116.40	117.60	—
	4.84	3.32	4.29	4.26	4.86	4.91	—
Key metrics
	203.20	154.10	178.90	160.30	177.40	173.10	—
	19.10%	15.40%	19.00%	19.90%	23.30%	22.90%	—
	10.90%	7.90%	10.90%	12.70%	15.30%	15.60%	—
	—	3.20%	—	4.50%	—	5.50%	—
	39.70%	32.80%	—	—	—	—	—
	-0.20%	-32.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	3,813	3,510	2,839	—
	78.90	72.00	107.20	—
	3,346	3,037	2,407	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	2,375	2,198	1,815	—
	22.00	19.30	22.00	—
	148.90	126.40	80.20	—
	799.60	693.80	489.80	—
	545.90	545.30	539.30	—
	-20.30	-20.30	0.00	—
	525.60	525.00	539.30	—
	124.70	123.90	132.60	—
	400.90	401.10	406.70	—
	16.71	16.72	17.15	—
Key metrics
	696.50	670.70	641.50	—
	18.27%	19.10%	22.60%	—
	10.51%	11.40%	14.30%	—
	—	15.40%	20.30%	—
	—	23.60%	—	—
	—	-1.40%	—	—
	—	606.50	411.90	—
	—	1.62	1.09	—
	—	0.00	0.00	—
	—	-300.80	-241.00	—
	—	83.3	84.6	—
Balance sheet
	—	4,620	3,326	—
	—	2,618	2,530	—
	—	300.80	241.00	—
	—	981.80	751.40	—
	—	0.00	0.00	—
	—	138.40	101.70	—
	—	194.00	134.90	—
	—	180.70	93.40	—
	—	1,086	564.50	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	3,139	2,616	—
Cash flow
	—	650.80	441.90	—
	—	-512.40	-682.70	—
	—	-82.60	287.50	—
	—	44.30	30.00	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	340.70	368.20	290.10	306.70	255.60	266.70	—
	33.90	6.10	22.60	17.50	32.10	35.20	—
	294.60	279.10	263.70	246.70	227.90	235.50	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	221.70	213.40	201.90	198.30	181.60	184.50	—
	2.70	3.10	1.80	2.00	1.70	1.50	—
	11.40	10.90	9.50	8.60	7.30	6.90	—
	58.80	51.70	50.50	37.80	37.30	42.60	—
	80.00	95.20	49.00	77.50	59.80	66.40	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	80.00	95.20	49.00	77.50	59.80	66.40	—
	20.10	23.10	14.20	17.60	14.70	12.20	—
	59.90	72.10	34.80	59.90	45.10	54.20	—
	2.49	3.00	1.45	2.50	1.88	2.26	—
Key metrics
	94.10	109.20	60.30	88.10	68.80	74.80	—
	27.60%	29.70%	20.80%	28.70%	26.90%	28.00%	—
	17.60%	19.60%	12.00%	19.50%	17.60%	20.30%	—
	—	4.50%	—	3.90%	—	3.50%	—
	33.30%	38.10%	—	—	—	—	—
	32.80%	33.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,306	1,221	1,094	—
	80.10	78.30	90.40	—
	1,084	1,018	945.50	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	835.30	795.20	759.20	—
	9.60	8.70	6.20	—
	40.40	36.30	26.20	—
	198.80	177.30	153.90	—
	301.70	281.40	238.50	—
	0.00	0.00	0.00	—
	301.70	281.40	238.50	—
	75.00	69.50	57.20	—
	226.70	211.90	181.30	—
	9.44	8.83	7.64	—
Key metrics
	351.70	326.40	270.90	—
	26.94%	26.70%	24.80%	—
	17.36%	17.40%	16.60%	—
	—	13.10%	12.50%	—
	—	11.60%	—	—
	—	16.90%	—	—
	—	301.50	112.50	—
	—	1.63	0.71	—
	—	0.00	0.00	—
	—	-48.50	-35.20	—
	—	76.5	128.0	—
Balance sheet
	—	2,482	2,150	—
	—	1,275	1,218	—
	—	48.50	35.20	—
	—	288.40	418.40	—
	—	0.00	0.00	—
	—	81.90	59.60	—
	—	112.60	52.80	—
	—	32.60	34.80	—
	—	273.80	189.50	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	2,080	1,888	—
Cash flow
	—	345.60	129.00	—
	—	-272.10	-824.70	—
	—	-62.60	717.30	—
	—	44.10	16.50	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 0.00%

Holder	Type	Holding	Previous	Change
Nadathur Fareast Pte Ltd	Public	21.87%	—	—
Manish Gupta	Public	8.91%	—	—
Rajesh Bhaskaran Nair	Public	7.14%	—	—
Bpc Genesis Fund I Spv Ltd	Public	5.75%	—	—
Sanjay S Parikh	Public	4.98%	—	—
Bpc Genesis Fund I A Spv Ltd	Public	2.98%	—	—
Gaurav Kapoor	Public	2.60%	—	—
Government Pension Fund Global	Public	2.57%	—	—
Vida Trustees Private Limited	Public	2.32%	—	—
Anand Kiran	Public	2.16%	—	—
Aarabhi Partners Consultants Llp	Public	2.09%	—	—
Sundaram Mutual Fund A/C Sundaram Mid Cap Fund	Public	1.90%	—	—
Fidelity Funds - India Focus Fund	Public	1.50%	—	—
Chestnut Associates Ptc Limited	Public	1.43%	—	—
Sycamore Philanthropy (Ptc) Limited	Public	1.43%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - Merger of Indirect Wholly owned subsidiaries of the Company in Germany10 Sep 2026 · Company Update / Restructuring
Intimation of Investors / Analysts Meeting8 Sep 2026 · Company Update / Analyst / Investor Meet
Update on Material Litigation under the Telephone Consumer Protection Act, 1991 involving Wholly- Owned Subsidiary, Indegene, Inc.31 Aug 2026 · Company Update / General
Intimation of Investors / Analysts Meeting19 Aug 2026 · Company Update / Analyst / Investor Meet
Update on Material Litigation under the Telephone Consumer Protection Act, 1991 involving Wholly-Owned Subsidiary, Indegene, Inc.19 Aug 2026 · Company Update / General
Transcript of the 28th Annual General Meeting held on August 13, 202617 Aug 2026 · AGM/EGM / AGM
Appointment of Ms. Jill Mary De Simone (DIN: 11483134) as an independent Director of the Company17 Aug 2026 · Company Update / Change in Directorate
Scrutinizer''s Report - 28th Annual General Meeting17 Aug 2026 · AGM/EGM / AGM
Intimation of Investors / Analysts Meeting14 Aug 2026 · Company Update / Analyst / Investor Meet
Proceedings of the 28th Annual General Meeting of the Company13 Aug 2026 · AGM/EGM / AGM
Intimation of Investors / Analysts Meeting12 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Investors / Analysts Meeting12 Aug 2026 · Company Update / Analyst / Investor Meet
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BPC Genesis Fund I- A SPV Ltd10 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BPC Genesis Fund I SPV Ltd10 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Transcript of earnings conference call on financial results for the quarter ended June 30, 20266 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of Newspaper Publication1 Aug 2026 · Company Update / Newspaper Publication
Audio Recording of the Q1 FY27 Earnings Call31 Jul 2026 · Company Update / Analyst / Investor Meet
Analyst Presentation and fact sheet - financial results for the quarter ended June 30, 202630 Jul 2026 · Company Update / Investor Presentation
Press Release30 Jul 2026 · Company Update / Press Release / Media Release
Monitoring Agency Report30 Jul 2026 · Company Update / Monitoring Agency Report
Allotment of Shares under ESOP Scheme 202030 Jul 2026 · Company Update / Allotment of ESOP / ESPS
Unaudited Financial Results for the Quarter ended June 30, 202630 Jul 2026 · Result / Financial Results
Outcome of the Board Meeting held on 30th July, 202630 Jul 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Newspaper Publication18 Jul 2026 · Company Update / Newspaper Publication
Letter to Shareholders in relation to Annual Report of the Company for the financial year 2025-2617 Jul 2026 · Company Update / General
Business Responsibility and Sustainability Report for the financial year 2025-2617 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report of the Company for financial year 2025-2617 Jul 2026 · Others / Reg. 34 (1) Annual Report
Notice of the 28th Annual General Meeting of the Company17 Jul 2026 · AGM/EGM / AGM
Intimation of Newspaper Publication16 Jul 2026 · Company Update / Newspaper Publication
Record date for payment of Final Dividend15 Jul 2026 · Corp. Action / Record Date
Outcome of the Board Meeting held on July 15, 202615 Jul 2026 · Others / Outcome without intimation
Intimation of Indegene Limited Q1 FY27 Earnings Call10 Jul 2026 · Company Update / Analyst / Investor Meet
Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated ....10 Jul 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI DP Regulations, 201810 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Investors / Analysts Meeting11 Jun 2026 · Company Update / Analyst / Investor Meet
Intimation of Investor Meeting3 Jun 2026 · Company Update / Analyst / Investor Meet
Revised Investor Presentation28 May 2026 · Company Update / Investor Presentation
Investor Presentation27 May 2026 · Company Update / Investor Presentation
Intimation of Investors / Analysts Meeting20 May 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.2500	31 Jul 2026	31 Jul 2026	—
Final Dividend - Rs. - 2.0000	13 Jun 2025	13 Jun 2025	—

Board meetings

30 Jul 2026 Board Meeting - Financial Results